|
USP7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.138000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.621200E-04 |
| Normal-vs-Stage2 |
4.097800E-02 |
| Normal-vs-Stage3 |
4.812800E-01 |
| Normal-vs-Stage4 |
7.118000E-01 |
| Stage1-vs-Stage2 |
9.888600E-01 |
| Stage1-vs-Stage3 |
1.356620E-01 |
| Stage1-vs-Stage4 |
3.466200E-01 |
| Stage2-vs-Stage3 |
2.974200E-01 |
| Stage2-vs-Stage4 |
4.670400E-01 |
| Stage3-vs-Stage4 |
9.887600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.055950E-02 |
| Normal-vs-AfricanAmerican |
2.501400E-03 |
| Normal-vs-Asian |
2.317200E-01 |
| Caucasian-vs-AfricanAmerican |
3.157600E-01 |
| Caucasian-vs-Asian |
9.624400E-01 |
| AfricanAmerican-vs-Asian |
6.687800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.967600E-04 |
| Normal-vs-Female |
3.915400E-01 |
| Male-vs-Female |
4.857800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.483200E-03 |
| Normal-vs-Extreme_Weight |
5.825500E-04 |
| Normal-vs-Obese |
1.699240E-01 |
| Normal-vs-Extreme_Obese |
5.716400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.865000E-01 |
| Normal_Weight-vs-Obese |
2.218800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.770800E-01 |
| Extreme_Weight-vs-Obese |
8.796000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.668000E-01 |
| Obese-vs-Extreme_Obese |
1.677600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.033200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.206100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.503600E-03 |
| Normal-vs-Age(81-100Yrs) |
6.39080000000014E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.938000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.481590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.879800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.078800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.856000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.210390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.022900E-03 |
| Normal-VS-Type2 PRCC |
7.9761000000067E-05 |
| Normal-VS-KIRP CIMP |
2.464100E-02 |
| Normal-VS-Unclassified PRCC |
4.212800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.620300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.92430000000221E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.017800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.10059999999191E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.660400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.375920E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.99886999999732E-05 |
| Normal-vs-N1 |
3.681400E-01 |
| Normal-vs-N2 |
7.213600E-01 |
| N0-vs-N1 |
1.795320E-04 |
| N0-vs-N2 |
3.340600E-01 |
| N1-vs-N2 |
4.445000E-01 |
|
|
